RETRACTION: Effects of silver nanoparticles coated with anti-HER2 on irradiation efficiency of SKBR3 breast cancer cells (Retraction of Vol 13, Pg 808, 2019)

被引：0
|
作者：
Aghamiri, Shahin
Jafarpour, Ali
Shoja, Mohsen
机构：
来源：
IET NANOBIOTECHNOLOGY | 2022年 / 16卷 / 06期
关键词：
D O I：
10.1049/nbt2.12087
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 34 条
  • [1] RETRACTED: Effects of silver nanoparticles coated with anti-HER2 on irradiation efficiency of SKBR3 breast cancer cells (Retracted article. See vol. 16, pg. 238, 2022)
    Aghamiri, Shahin
    Jafarpour, Ali
    Shoja, Mohsen
    [J]. IET NANOBIOTECHNOLOGY, 2019, 13 (08) : 808 - 815
  • [2] Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer (vol 45, pg 112, 2019)
    Lee, Jeong-Yeon
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (12) : 1364 - 1364
  • [3] RETRACTION: Oxymatrine Inhibits the Proliferation and Invasion of Breast Cancer Cells via the PI3K Pathway (Retraction of Vol 11, Pg 10499, 2019)
    Guo, L.
    Yang, T.
    [J]. CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2289 - 2289
  • [4] Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+breast cancer model (SKBR3)
    Rodallec, Anne
    Sicard, Guillaume
    Giacometti, Sarah
    Carre, Manon
    Maia, Thomas
    Valette, Margaux
    Bouquet, Fanny
    Savina, Ariel
    Lacarelle, Bruno
    Ciccolini, Joseph
    Fanciullino, Raphaelle
    [J]. ANTI-CANCER DRUGS, 2020, 31 (05) : 463 - 472
  • [5] RETRACTION: Cinobufagin Suppresses the Characteristics of Osteosarcoma Cancer Cells by Inhibiting the IL-6-OPN-STAT3 Pathway (Retraction of Vol 13, Pg 4075, 2019)
    Zhang, C.
    Ma, K.
    Li, W. Y.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 4445 - 4445
  • [6] RETRACTION: Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer (Retraction Article, vol 26, pg 854, 2019) (Retraction of Vol 26, Pg 854, 2019)
    Liu, Lei
    Hu, Yunhui
    Zhang, Sheng
    Li, Xiru
    Zhang, Jin
    [J]. BREAST CANCER, 2019, 26 (06) : 854 - 854
  • [7] RETRACTION: Anti-proliferation and anti-metastatic effects of sevoflurane on human osteosarcoma U2OS and Saos-2 cells (Retraction of Vol 108, Pg 121, 2019)
    Gao, Ke
    Su, Zhen
    Liu, Hailin
    Liu, Yan
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2022, 127
  • [8] RETRACTION: Trastuzumab-modified DM1-loaded nanoparticles for HER2+breast cancer treatment: an in vitro and in vivo study (Retraction of Vol 46, Pg 1708, 2018)
    Rong, Ling
    Zhou, Shuping
    Liu, Xinkuang
    Li, Amin
    Jing, Tao
    Liu, Xueke
    Zhang, Yinci
    Cai, Shiyu
    Tang, Xiaolong
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) : 1301 - 1301
  • [9] RETRACTION: Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells (Retraction of Vol 12, Pg 933, 2019)
    Hu, C.
    Zhuang, W.
    Qiao, Y.
    [J]. ONCOTARGETS AND THERAPY, 2022, 15 : 1045 - 1045
  • [10] RETRACTION: LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p (vol 13, pg 1803, 2021) (Retraction of Vol 13, Pg 1803, 2021)
    Yu, H.
    Dong, L.
    Wang, H.
    [J]. CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 739 - 739
1234